# Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis

> **NCT00536627** · PHASE1,PHASE2 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 70 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **BIOLOGICAL:** DNA vaccine pCMVS2.S

## Key facts

- **NCT ID:** NCT00536627
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00536627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00536627, "Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00536627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*